{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:08:13Z","timestamp":1785276493613,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270544"],"award-info":[{"award-number":["81270544"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatobiliary & Pancreatic Diseases International"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.hbpd.2018.02.004","type":"journal-article","created":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T07:39:00Z","timestamp":1519025940000},"page":"133-139","source":"Crossref","is-referenced-by-count":6,"title":["CD4 + Foxp3 + CD25 +\/\u2212 Tregs characterize liver tissue specimens of patients suffering from drug-induced autoimmune hepatitis: A clinical-pathological study"],"prefix":"10.1016","volume":"17","author":[{"given":"Li-Mei","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Brigstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run-Ping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2018.02.004_bib0001","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0002","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0003","doi-asserted-by":"crossref","first-page":"E79","DOI":"10.1111\/hepr.12532","article-title":"Natural history and outcomes in drug-induced autoimmune hepatitis","volume":"46","author":"Yeong","year":"2016","journal-title":"Hepatol Res"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0004","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s10620-009-0805-5","article-title":"Meloxicam as a cause of drug-induced autoimmune hepatitis","volume":"55","author":"Mart\u00ednez-Odriozola","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0005","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-065X.2011.01018.x","article-title":"Regulatory T cells and Foxp3","volume":"241","author":"Rudensky","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0006","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0007","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jhep.2012.02.029","article-title":"FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency","volume":"57","author":"Peiseler","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0008","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.4049\/jimmunol.182.3.1689","article-title":"Phenotypic and functional analysis of CD4+ CD25\u2212 Foxp3+ T cells in patients with systemic lupus erythematosus","volume":"182","author":"Bonelli","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0009","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3109\/08916930903541190","article-title":"T regulatory cells lacking CD25 are increased in MS during relapse","volume":"43","author":"Fransson","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0010","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/rheumatology\/kes039","article-title":"Effects of glucocorticoid treatment on CD25\u2212FOXP3+ population and cytokine-producing cells in rheumatoid arthritis","volume":"51","author":"de Paz B","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0011","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/08916934.2014.992518","article-title":"Extension of the CD4+Foxp3+CD25(\u2212\/low) regulatory T-cell subpopulation in type 1 diabetes mellitus","volume":"48","author":"Z\u00f3ka","year":"2015","journal-title":"Autoimmunity"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0012","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0013","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/hepr.12931","article-title":"Challenges and difficulties in pathological diagnosis of autoimmune hepatitis","volume":"47","author":"Harada","year":"2017","journal-title":"Hepatol Res"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0014","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaut.2015.10.006","article-title":"The clinical phenotypes of autoimmune hepatitis: a comprehensive review","volume":"66","author":"Wang","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5009\/gnl15352","article-title":"Diagnosis and management of autoimmune hepatitis: current status and future directions","volume":"10","author":"Czaja","year":"2016","journal-title":"Gut Liver"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0016","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/CEG.S101440","article-title":"Autoimmune hepatitis: current challenges and future prospects","volume":"10","author":"Aizawa","year":"2017","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0017","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10620-012-2445-4","article-title":"Acute and acute severe (fulminant) autoimmune hepatitis","volume":"58","author":"Czaja","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0018","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug-induced liver injury","volume":"89","author":"Aithal","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0019","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0168-8278(03)00005-9","article-title":"Milestones in liver disease: scoring chronic hepatitis","volume":"38","author":"Desmet","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0020","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/00042737-199612000-00001","article-title":"Scoring of liver biopsies: are we doing it right?","volume":"8","author":"Scheuer","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0021","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug-induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","author":"Bj\u00f6rnsson","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0022","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.dld.2014.08.040","article-title":"Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: a retrospective cohort study","volume":"46","author":"Licata","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0023","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.24481","article-title":"The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury","volume":"54","author":"Suzuki","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0024","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jhep.2014.08.005","article-title":"Regulatory T cells and autoimmune hepatitis: what happens in the liver stays in the liver","volume":"61","author":"Oo","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0025","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/eji.200838168","article-title":"Is FOXP3 a bona fide marker for human regulatory T cells?","volume":"38","author":"Roncarolo","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0026","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/intimm\/dxn002","article-title":"STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25\u2212 effector T cells","volume":"20","author":"Passerini","year":"2008","journal-title":"Int Immunol"},{"key":"10.1016\/j.hbpd.2018.02.004_bib0027","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000440747","article-title":"Role of histopathology in autoimmune hepatitis","volume":"33","author":"Tiniakos","year":"2015","journal-title":"Dig Dis"}],"container-title":["Hepatobiliary & Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387218300493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387218300493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T00:52:35Z","timestamp":1535071955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387218300493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1499387218300493"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2018.02.004","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}